San Francisco Bay Area biotech stories.
Friday, July 20, 2012
Astex leukemia drug nets European recommendation
An advisory committee to Europe’s drug regulator recommended Friday that the agency approve a drug licensed out of Dublin-based Astex Pharmaceuticals Inc. for patients with acute myeloid leukemia
The European Medicines Agency’s Committee for Medical Products for Human Use recommended that Dacogen injections be approved for people 65 or older with newly diagnosed or secondary AML who are not eligible for standard chemotherapy.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)